The S&P 500 Futures are rebounding after they closed sharply lower yesterday as tech-led sell-off continued.
Later today, the U.S. Labor Department will report JOLTS job openings for July (6 million expected).
European indices are rebounding after they consolidated following announcement by AstraZeneca it halts clinical trials in Japan for Covid-19 vaccine for safety reasons.
Asian indices faced a drop this morning, following Wall Street sell-off.
WTI Crude Oil futures remain bearish after they plummeted 7.6% yesterday. Later today, American Petroleum Institute (API) would release the change of U.S. oil stockpile data for September 4.
Gold remains under pressure and declined 9.33$ (-0.48%) to 1922.7.
EUR/USD declined 13pips to 1.1765, the day's range was 1.1753 - 1.1787 compared to 1.1766 - 1.1827 the previous session ahead of the ECB meeting tomorrow.
U.S. Equity Snapshot
Lululemon Athletica's (LULU) shares are under pressure in premarket trading after the designer of athletic accessories and apparel said it expects adjusted profit in its current third fiscal quarter to fall as much as 20% because of higher marketing costs. The company reported second quarter adjusted EPS of 0.74 dollar, beating the estimate, down from 0.96 dollar a year ago.
Source: GAIN Capital, TradingView
Slack Technologies (WORK) shares are heavily down in premarket trading after the collaboration hub announced second quarter LPS of 0.13 dollar, below the forecast, up from an LPS of 0.98 dollar last year on revenue of 215.9 million dollars up from 145.0 million dollars a year earlier.
Northrop Grumman (NOC), an aerospace and defense technology company, announced that it has secured a 13.3 billion dollars contract from the U.S. Air Force for the modernization of the nation's intercontinental ballistic missile (ICBM) system.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.